Philadelphia, PA – April 13, 2011 – The Florida Comprehensive Care Network (FCCN) and ITA Partners, Inc. (ITA), have signed a long term strategic agreement under which FCCN will use eviti, ITA’s oncology decision-support platform, across its network of oncologists. ITA is an independent, third-party expert with nearly a decade of experience supporting oncology treatment decisions and patient care.
FCCN is a state-wide network of medical and radiation oncologists providing comprehensive, evidence-based care to cancer patients in the State of Florida. Using eviti, a web-based platform, FCCN member oncologists will be presented with evidence-based treatment options for each patient – in real time – at the point of prescribing. eviti goes beyond pathways to facilitate value-based oncology care aligning physicians and payers for quality patient care.
Click to read more
“eviti is an ideal platform for our business model. Our physicians are committed to providing treatment that has been demonstrated to be effective. eviti gives them access to all evidence-based options at the point of care, allowing them to more efficiently make informed and effective treatment plan decisions that align with the patient’s insurance plan language,” said Craig Deligdish, MD, chief medical officer for FCCN.
“Our common goal of appropriate, cost-effective treatment for every patient makes the ITA-FCCN partnership valuable to patients, providers and payers. eviti will help break down information barriers, assuring that each patient is prescribed evidence-based care,” said Eduardo Beruff, president and chief executive officer for ITA.
eviti is the first independent, fully-integrated solution that simultaneously addresses the quality and cost concerns of cancer patients, oncologists and insurance companies, in any treatment setting. Patients benefit from appropriate treatment for their cancer, while physicians are empowered with systematic access to the latest, most comprehensive, evidence-based treatment standards, as well as the benefit of streamlined reimbursement. Payers are assured that members are receiving cost-effective care within the scope of their plan benefits.
eviti was launched nationally in October 2010 to provide access to the best cancer treatment decision support available and to advance the performance in the delivery of quality care.
